Riskpilot← Back to searchSign inGet full accessKJETIL SKAANSAR AS
ASActiveOrg 920572782Roavegen 8A, 2613 LillehammerMedical specialists activities · NACE 8622Est. 20181 employees
Revenue 2025
NOK 0
EBITDA margin
—
-102% vs 2024
Equity ratio
50.7%
Financial strength
Net profit 2025
NOK 59K
-95% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -28K | -102% |
| Net profit | NOK 59K | -95% |
| Total assets | NOK 2,5M | -4% |
| Equity | NOK 1,3M | +5% |
| Employees | 1 | — |
Legal name
KJETIL SKAANSAR AS
Org number
920572782
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
9. mars 2018
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Legespesialistvirksomhet innen øre- nese- halsfaget, herunder tilpasning og salg av produkter som faller inn under dette fagområdet. Investering og deltakelse i andre selskaper, herunder også investering i eiendom, samt alt annet som naturlig faller inn under dette.
Address
Roavegen 8A, 2613 Lillehammer
Phone
+4795846992
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 237 | 5 468 | 4 322 | 2 520 | 0 |
| Staff expenses | −1 120 | −3 729 | −1 087 | −336 | −0 |
| EBITDA | 2 084 | −550 | 679 | 1 306 | −28 |
| Depreciation & amort. | −5 | −0 | −0 | −0 | −0 |
| EBIT | 2 079 | −550 | 679 | 1 306 | −28 |
| Net financials | −0 | 2 | 35 | 151 | 104 |
| Profit before tax | 2 079 | −548 | 714 | 1 457 | 77 |
| Tax | 457 | −121 | 156 | 321 | 17 |
| Net profit | 1 622 | −428 | 558 | 1 137 | 59 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 696 | 3 626 | 2 878 | 2 576 | 2 475 |
| Equity | 2 029 | 1 601 | 2 159 | 1 196 | 1 255 |
| Long-term debt | 1 | 0 | 36 | 223 | 173 |
| Short-term debt | 666 | 2 025 | 682 | 1 157 | 1 047 |
| Total debt | 667 | 2 025 | 718 | 1 380 | 1 220 |
EBITDA margin
-2754800.0%
This company
15.8%
Market median
-17435543% vs market
20212025
Equity ratio
50.7%
This company
38.2%
Market median
+33% vs market
20212025
Return on equity
4.7%
This company
18.4%
Market median
-74% vs market
20212025
Net profit margin
5922700.0%
This company
8.1%
Market median
+73119653% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
BE Deputy Member | Deputy Member | 2018 |
KS Chief Executive Officer | Chief Executive Officer | 2018 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KJETIL SKAANSAR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Berit Elisabeth Fougner | Deputy Member | 0 companies |
| Kjetil Skaansar | Chief Executive Officer | 0 companies |